BioXcel Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has BioXcel Therapeutics's balance sheet done over the years? Its assets were worth $73,702,000 last year, which is less than in the previous period. 177% of BioXcel Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $130,210,000, which means an increase by 1% compared compared to last year.

Debt to Assets

BioXcel Therapeutics, Inc. (NASDAQ:BTAI): Debt to assets
2016 7000 331K 4728.57%
2017 1355000 2.33M 172.47%
2018 43549000 4.66M 10.7%
2019 36392000 9.49M 26.1%
2020 219936000 13.24M 6.02%
2021 239439000 17.77M 7.42%
2022 205853000 129.07M 62.7%
2023 73702000 130.21M 176.67%

BTAI Balance Sheet (2016 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016
Assets
Current assets:
Cash and cash equivalents
65.22M193.72M232.96M213.11M32.42M42.56M887K0
Short term investments
00000000
Net receivables
71K248K000115K00
Inventory
1.99M1.98M000000
Other current assets
4.86M3.84M956K3.94M1.68M491K3K2K
Total current assets
72.14M202.86M232.96M217.06M34.10M43.17M890K2K
Non-current assets:
Property, Plant and Equipment
1.47M2.06M2.54M2.78M2.23M327K4K5K
Goodwill
00000000
Intangible assets
00000000
Long term investments
00000000
Other non-current assets
87K925K3.93M87K51K51K461K0
Total non-current assets
1.55M2.98M6.47M2.87M2.28M378K465K5K
Total assets
73.70M205.85M239.43M219.93M36.39M43.54M1.35M7K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0007.38M-164K000
Short term debt
346K319K293K237K164K0371K0
Total current liabilities
27.26M32.89M16.66M11.84M8.46M4.66M2.33M331K
Non-current liabilities:
Long term debt
101.03M93.83M1.10M1.39M1.02M000
Deferred tax
00000000
Other non-current liabilities
1.90M2.34M000000
Total non-current liabilities
102.94M96.18M1.10M1.39M1.02M000
Total liabilities
130.21M129.07M17.77M13.24M9.49M4.66M2.33M331K
Data sourceData sourceData sourceData sourceData sourceData source